argenx Announces Extraordinary General Meeting of Shareholders on February 27, 2023 to Appoint Steve Krognes as Non-Executive Director
January 16, 2023 Amsterdam, the Netherlands – argenx SE , a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced an... | January 16, 2023